Pharma companies in India and abroad are aggressively working to develop new molecules for treatment epilepsy. Globally, neuropsychiatry category is known to be the second fastest growing segment after cardiovascular-diabetic drugs.
From: www.pharmabiz.com
Aggressive research on for newer epilepsy drugs by pharma majors
Posted by Ruslan Abuzant at 6:02 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment